Blood Copyright Transfers Do You Need to Do Them Before Review

How to submit an article

Note: articles sent by e-postal service will non be accepted.Please, submit your manuscript to Publishing Manager.

Our Periodical uses certified plagiarism checker software (iThenticate® and Grammarly®) to verify the authenticity of articles and discover duplications from each article content online against billions of web pages.

Upload the Copyright Transfer when you submit the article.

ISI Journal Citation Reports^® Ranking: 2016, Pharmacology & Pharmacy

2020 Bear on Cistron: 3.507

five-Year Impact Factor 3.111

Instructions for Authors

European Review for Medical and Pharmacological Sciences (Eur Rev Med Pharmacol Sci) is an open-access journal. It upholds a peer-reviewed, rapid, and rigorous original manuscript treatment and editorial process. It publishes Editorials, Reviews, Original Papers, and Scientific Correspondence on subjects regarding Experimental, Laboratory and Clinical Medicine, and Pharmacology. Eur Rev Med Pharmacol Sci is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug prophylactic, and meta-analyses. Reviews should include systematic revision of the literature concerning the treated topics and preferably meta-analyses, original illustrations, and tables. European Review for Medical and Pharmacological Sciences doesn't take for the publication "information not shown" or "unpublished data". Letters are restricted to the discussion of papers already published in the periodical, with a maximum of 300 words, one tabular array or figure, and up to ten references.

Curt Reports and Case Reports will be considered for publication only if of item interest and accompanied past a brusk review.  The structured abstract must non exceed 200 words.

Please note that the journal employs a plagiarism detection system. By submitting your manuscript to the journal you accept that your manuscript may exist screened for plagiarism against previously published work.

Manuscript Submission

Authors should submit manuscripts including figures to the Eur Rev Med Pharmacol Sci – please read and apply the loading instructions given on this website, noting that all information entered during the submission process related to the manuscript should besides be included, and be identical to the final submitted version of the manuscript – delight run into full details under "Presentation of Manuscripts". Authors should as well provide all supplementary information required to understand and verify the research presented in the article. Submitted papers should exist well formatted in grammatically correct English. Papers must be submitted exclusively to the Journal, and are accepted on the agreement that they have not been, and won't be, published elsewhere. The correspondence for each article must be carried on only past the corresponding author. Corresponding Authors should provide an institutional and verified email accost. Articles without this requirement won't be considered for evaluation or publication. The submission procedure requires a full declaration of the personal interests of all Authors and funding interests; these details should also exist included in the text of the manuscript (see below).

Authorship

Authors must fulfill the following criteria:

• He/she must have made a substantial contribution to research design, or to the acquisition, analysis or interpretation of data;
• He/she must accept drafted the paper or revised it critically;
• He/she must take given approving of the submitted and final versions.

Copyright Transfer Agreement: Eur Rev Med Pharmacol Sci Authors will be required to sign a Copyright Transfer Agreement (click to download PDF) for all papers accepted for publication. The signature of the CTA is a condition of publication and papers will not be passed to the publisher for production unless a signed form has been received. Afterwards submission, authors cannot submit their manuscripts to other journals. Later acceptance, the Publisher retains the rights of the newspaper. To assist Authors, an appropriate CTA class volition be supplied by the editorial function. The original completed Copyright Transfer Agreement must be signed by the corresponding Author and sent by email to European Review for Medical and Pharmacological Sciences. The Editors retain the usual right to modify the style and length of a contribution (major changes existence agreed with the respective Author) and to decide the fourth dimension of publication.

Changes to authorship

Authors should consider advisedly the list and order of authors earlier submitting their manuscript and provide the definitive list of authors at the time of the first submission. Whatsoever deletion, addition or rearrangement of author names in the authorship list tin can exist made just earlier the manuscript has been accepted and only if approved past the Editor-in-Chief.

To asking this change, the Editor-in-Chief must receive a alphabetic character from the Corresponding Writer (at submission@europeanreview.org) specifying the reason for the alter in the author listing, along with a written confirmation letter from all authors that they agree with the removal, addition, or rearrangement. In the case of removal or addition of authors, this includes confirmation from the author being removed or added.

Cover Alphabetic character

Authors who submit manuscripts to Eur Rev Med Pharmacol Sci must provide a supporting Cover Letter that briefly details the commodity'due south relevance to the journal's audience and how the article advances agreement of the field. The Comprehend Letter of the alphabet must include contact information [affiliation, postal accost, e-mail address, phone number] for all authors. Authors should betoken aRespective Author for correspondence during the submission and revision process. In the Letter of the alphabet, authors must confirm that the manuscript has been submitted solely to this periodical and is non published, in press, or submitted elsewhere (including preprint servers). Authors must confirm that all the research meets the upstanding guidelines, including adherence to the legal requirements of the study country. Authors must confirm that the manuscript has been read and approved by all authors. Comprehend Letter of the alphabet must be signed by the Corresponding Writer on behalf of all the other authors.

Presentation of Manuscripts

Original Articles should present novel works that brand a significant impact inside the aims and scope of the journal, and which provide an important advancement in the reader's knowledge or understanding. Supporting information or additional experimental details can be submitted equally Supplementary Information.

A title page must contain the Authors' names, title, and affiliations, plus the full contact details of the Respective Author, including their current institutional and/or academic email address. Authors are asked to provide a full and a short running title, together with a small number of keywords (minimum of three words) for indexing purposes.

The text should kickoff with a structured Abstract, not exceeding 270 words, organized into sections using all of the post-obit headings OBJECTIVE, MATERIALS AND METHODS or PATIENTS AND METHODS, RESULTS, CONCLUSIONS.

Please, check our guidelines earlier submitting your manuscript.

The newspaper should and then go along conventionally: Objective or Introduction, Materials and Methods or Patients and Methods, Results, Discussion, Conclusions, and References. Pages should be numbered consecutively in Arabic numbers, including at the terminate of the manuscript or separately in another file tables, figure legends (with magnifications if needed), acknowledgments, and declaration of conflict or funding interests. Review Articles and Systematic Reviews also require a structured summary using all of the post-obit headings: OBJECTIVE, MATERIALS AND METHODS or PATIENTS AND METHODS (e.g., search terms used), RESULTS (avoid vague statements e.k., '…will be discussed'), (e.thou., need for future studies).

References must be numbered in the order in which they are get-go mentioned in the text, and should be identified in the text, tables, and legends by Standard arabic numbers in superscript. The Us National Library of Medicine and used in Alphabetize Medicus applies (for more details see the section "References"). References must be verified by the Authors against the original documents.

Authors should observe the following guidelines.

1. Practise not attempt to make your output approximate or match the typeset page.
2. Be consequent in manner (i.e., units, abbreviations).
3. Stop paragraphs in a uniform style, and in a different fashion from line endings within paragraphs. A often used paragraph ending is simply two carriage returns.
4. Utilise double spacing in your document. Do non add extra line spacing (except equally a normal paragraph catastrophe indication) above or below titles, subheads, or betwixt paragraphs.
5. Avoid using multiple spaces (horizontal) in your electronic manuscript. End sentences with only one infinite. Never use multiple spaces for horizontal positioning of text.
6. Tables and figure captions should exist prepared in carve up files. The authors accept to signal this textile within the text.
7. Authors have to provide this information immediately after the main text.

Additional tables or figures and/or extra methodological particular tin be included in a carve up Supplementary Appendix.

Authors who want to publish on our Journal must follow the guidelines on Good Publication Practice as reported inCOPE and Council of Scientific discipline Editors. These guidelines aim to ensure that articles are published in a responsible and ethical manner.

Clinical Trials

All clinical trials submitted to European Review for Medical and Pharmacological Sciences for consideration of publication must be registered. The International Commission of Medical Journal Editors (ICMJE) defines a clinical trial equally "whatever enquiry projection that prospectively assigns human being subjects to intervention or comparison groups to study the cause-and-effect human relationship between a medical intervention and a health issue. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase 1 trials), are exempt."

For definitions and further information, please encounter the department http://www.icmje.org/recommendations/browse/publishing-and-editorial-problems/clinical-trial-registration.html found in ICMJE'south Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Please notation, that, different ICMJE, ADA does not require trials to be registered before enrollment begins, although Diabetes does encourage this practice. When submitting your manuscript, delight include the unique trial number and the name of the registry (e.grand., ClinicalTrials.gov or ISRCTN) at the end of the abstruse and in your embrace letter.

Systematic Reviews and Meta-Analyses

A systematic review analyzes a defined research question by collecting and summarizing all empirical evidence that fits pre-specified eligibility criteria.

A meta-analysis reports the use of statistical methods to summarize the results of these studies.

To conduct a high-quality analysis, the authors are requested to follow some specific guidelines:

• authors take to clearly state objectives with pre-divers eligibility criteria for studies (e.g., inclusion and exclusion criteria, etc.);
• the authors take to clearly depict the methods used for locating, selecting, extracting, and synthesizing data;
• the methodology should exist accurate and reproducible;
• the authors have to deport a systematic search that aims at identifying all relevant studies;
• the authors accept to appraise the validity of the findings of the included studies (due east.g., take chances of bias);
• the authors accept to present a systematic analysis with detailed characteristics and findings of the included studies.

According to the International Committee of Medical Journal Editors (ICMJE), Authors have to follow guidelines of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA).

Other studies

Other guidelines have been developed and should be followed for different study designs:

• Consort for randomized trials;
• STROBE for observational studies;
• STARD for studies of diagnostic accuracy.

In item, skilful sources for reporting guidelines are the EQUATOR Network and the NLM's Research Reporting Guidelines and Initiatives.

Ethics

An Ethics Commission should have approved human and animal studies but in questionable matters, the Editors reserve the right to reject papers.

All investigators should ensure that the planning conduct and reporting of human research are in accordance with the Proclamation of Helsinki. All authors should seek approval to acquit enquiry from an contained local, regional or national review body (east.k., ethics committee, institutional review board). If dubiousness exists whether the research was conducted in accord with the Proclamation of Helsinki, the authors must explain the rationale for their approach and demonstrate that the local, regional or national review body explicitly canonical the doubtful aspects of the study. Approval by a responsible review body does not preclude editors from forming their own judgment whether the conduct of the research was advisable.

Animal Ethics

When reporting experiments on animals, authors should bespeak whether institutional and national standards for the care and use of laboratory animals were followed. This statement is mandatory for acceptance and publication of the manuscript.

Informed Consent

Appropriate consents, permissions and releases must be obtained where authors wish to include case details or other personal information or images of patients and any other individuals in their publication. This is to comply with all applicable laws and regulations concerning the privacy and/or security of personal information, including, but not limited to the Full general Data Protection Regulation (GDPR) (EU) 2016/679.

Patients have a correct to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether whatsoever potential identifiable material might exist available via the Internet as well as in print after publication.

The following statement should exist included in each manuscript submitted to our periodical:

Informed consent: Informed consent was obtained from all individual participants included in the report.

Some Considerations

• Images of patients or enquiry subjects should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent.
• If identifying characteristics are contradistinct to protect anonymity, authors should provide assurances that such alterations do non distort scientific meaning.
• Formal consents are not required for the use of entirely anonymized images from which the individual cannot be identified – for case, x-rays, ultrasound images, laparoscopic images, etc.
• If consent has not been obtained, it is mostly not sufficient to anonymize a photograph merely by using eye confined or blurring the face of the individual concerned.

References

This department has to include the most contempo studies that accept been done on that topic.

When reporting the reference numbers in the text, you must follow these rules: "1-2" must be written as "ane,2" and then on. Y'all have to put "-" just in case you have many consecutive numbers. For instance: "1,2,3,four,5,half dozen" must be written as "1-6";

References' numbers must follow a chronological order within the text and must exist inserted before the punctuation (Yep ¹². NO.¹²)

Consummate all the references in accordance with the Instructions for the authors (see How to submit an article, europeanreview.org): yous have to list all the authors (NOT et al), the year without the month of publication, delete the number of the single upshot afterwards the volume'southward number, name of the journal: write the international acronyms without any punctuation; you must put a space subsequently semicolon and colon (NOT 2014;2014:907915, Aye 2014; 2014: 907915); moreover, initial and final pages must be entirely reported (NOT 135-46; Yep 135-146).

In the references, you must enter a space after semicolon and colon

• YES: Garcia-Contreras M, Brooks RW, Boccuzzi L, Robbins PD, Ricordi C. Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus. Eur Rev Med Pharmacol Sci 2017; 21: 2940-2956.
• NOT: Garcia-Contreras Yard, Brooks RW, Boccuzzi L, Robbins PD, Ricordi C. Exosomes as biomarkers and therapeutic tools for type one diabetes mellitus. EurRevMedPharmacolSci 2017;21:2940-2956.

In the references, yous must substitute "and" with "," (comma) earlier the final author's proper noun;

In the references, all the authors must be written with the same character size. You must write only the start letter in upper-case letter letter of the alphabet, without changing the size of them.

(Not) Instance 1: NAINAN OV, XIA Chiliad, VAUGHAN Yard, MARGOLIS HS. Diagnosis of hepatitis A virus infection: A molecular approach. Clinical Microbiology Reviews 2006:nineteen:63-79.

(YES) Example i: Nainan OV, Xia One thousand, Vaughan M, Margolis HS. Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev 2006; xix: 63-79.

(NOT) Example 2: DA. Baidal, C. Ricordi, Chiliad. Garcia-Contreras, A. Sonnino, A. Fabbri. Combination high-dose omega-3 fat acids and high-dose cholecalciferol in new onset type 1 diabetes: A potential role in preservation of beta-cell mass. Eur Rev Med Pharmacol Sci. 2016 Jul;20(xv):3313-8.

(Yeah) Instance ii: Baidal DA, Ricordi C, Garcia-Contreras Thousand, Sonnino A, Fabbri A. Combination loftier-dose omega-3 fat acids and loftier-dose cholecalciferol in new onset blazon ane diabetes: a potential role in preservation of beta-cell mass. Eur Rev Med Pharmacol Sci 2016; xx: 3313-3318.

Commendation of a book: Scuderi Due north, Toth BA. International Textbook of Aesthetic Surgery. Springer International Publishing, 2016.

Illustrations and Tables

Figure legends should be included in the chief text of the manuscript and not course part of the figures. The authors are encouraged to transport the highest-quality figures possible. Click here for Figure details.

For the accepted file format, encounter beneath:

Document Files	Graphic Files	Graphic Files
• Word	• GIF • TIF (or TIFF) • EPS • PNG • JPG (or JPEG) • BMP	• Quicktime •  MPEG • AVI

The figure resolution/specification for various types of original figures, at their final size, should exist as follows: Line fine art – Minimum 600 dpi, measuring preferably 13 by 18 cm and no more than xx by 25 cm in size. Halftone (i.e., both B/Westward and Color photographs) – Minimum 300 dpi, measuring preferably thirteen past eighteen cm and no more xx by 25 cm in size. Line and tone (line art and halftone combined) – Minimum 600 dpi, measuring preferably thirteen by 18 cm and no more than xx by 25 cm in size.

For line figures, the lines should be solid, the text in a standard font and non blurred, and the overall image should exist sharp and clear. Avoid using tints if possible; if they are essential to the understanding of the figure, try to make them fibroid. As a guide, if the electronic files are viewed at 400% on the computer screen and they await blurred or pixelated in any manner then they will NOT be of sufficient quality for printing.

Tables should exist cocky-independent and complete; they must not duplicate the data already contained in the text. They should exist supplied as editable files (preferably word files), not pasted as images. All abbreviations must exist divers in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that guild) and *, **, *** should be reserved for p-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure and table legends must be able to stand lonely in the text and thus total descriptive legends for all figures and tables should be supplied.

Units and Abbreviations

All measurements should be in SI units with the exception of hemoglobin (g/dL) and blood pressure (mmHg). Original observations recorded in other units should be stated, together with the appropriate conversion factors. Standard abbreviations, without punctuation, are used. Units, Symbols and Abbreviations (1988) published by the Royal Society of Medicine, and SI: The International System of Units (1982) from HMSO both provide useful guides. Abbreviations, used sparingly, should follow the kickoff total spelling, in parentheses. A list of abbreviations at the starting time of the article is accepted just if they are more than viii.

Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever advisable. Sequence variant nomenclature must follow the current HGVS guidelines in which some examples of acceptable nomenclature are provided.

Drug Names

Generic names should, in general, exist used. If an Author desires, brand names may exist inserted in parentheses. Drug names are spelled out according to the European Pharmacopoeia, but the American spelling should be used afterward the first utilise of a drug name.

Statistics

Methods should be referenced. 2-tailed significance tests should be used unless explicitly stated. Controls should be described as completely as experimental subjects. Measures of location should be accompanied by measures of variability (e.g., mean and conviction intervals) every bit well as conventional probability values. Clinical trial reports should include the power of the study blueprint.

Financial Back up

Sources of financial back up during the last two years must be acknowledged. Delight read the following statements, adding those sections, which are relevant at the finish of your submitted manuscript under a heading 'Argument of Interests'.

1. Authors' annunciation of personal interests: (i) [Proper noun of individual] has served as a speaker, a consultant and an advisory lath member for [names of organizations], and has received enquiry funding from [names of organization]. (two) [Name of private] is an employee of [name of organization]. (iii) [Name of individual] owns stocks and shares in [proper noun of organisation]. (iv) [Name of private] owns patent [patent identification and brief description].
2. Proclamation of funding interests: (i) This study was funded [in part or in full] by [insert proper noun of funding organization], grant number [insert grant or some other identification number]. (ii) The [writing or training] of this paper was funded in part by [insert name of funding organization]. (iii) Initial information analyses were undertaken by [name of individuals if not listed as Authors] who are employees of [name company] and received funding from [insert name of funding organization]. (four) Writing support was provided by [insert name of individual(s)] of [proper noun company] and funded past [insert name of funding organization].

Conflicts of Involvement (COI)

At the time of submission, European Review for Medical and Pharmacological Sciences policy requires that authors reveal whatsoever COI, including financial interests or connections, direct or indirect, or any other situations that could raise questions of bias in either the reported work or the conclusions, implications, or opinions stated. Disclosed potential COIs should include any relevant commercial or other sources of funding for either author(southward), or the sponsoring institution, the associated department(s) or organization(southward). When considering whether yous should declare a COI delight consider the following question: Is in that location whatsoever system that would embarrass you or any of your co-authors did not declare and that would emerge later on publication and you had not declared it?

As an integral part of the online submission process, respective authors are required to confirm whether they or their co-authors take any conflicts of interest to declare and to provide details of these. If the corresponding author is unable to confirm this information on behalf of all co-authors, the authors in question will then be required to submit a completed COI form to the Editorial Office. It is the Corresponding author's responsibility to ensure that all authors adhere to this policy.

If the manuscript is published, COI data will be communicated in a statement within the published piece of work.

Well-nigh unethical publication practice, we follow the guidelines onGood Publication Exercise equally reported inCOPE andCouncil of Science Editors.

Revised Articles

Revised articles must be submitted once again within 2 months, or else will be considered as withdrawn.

Accepted Articles

The accepted articles must exist paid earlier publication. Payment is due within 30 days from acceptance. Articles are published within three months from the payment date.

Galley Proofs

The corresponding Author volition receive an e-mail with a pdf file of the galley proof. The galley proof can exist downloaded every bit a PDF (portable document format) file. Acrobat Reader volition be required in club to read this file. This will enable the file to be opened, read on-screen and printed out in order for any corrections to be added. Excessive changes (i.e. over 100 characters) made by the Author to the proofs, excluding typesetting errors, won't be made. Authors are asked to carefully cheque the galley proofs (particularly regarding the name of Authors, affiliations, and corresponding Authors) as after its approval no further changes will exist possible.

Reprints

Paper reprints shall be charged. Electronic offprints are sent to the first Writer at his/her first email address on the title page of the paper, on request. For this reason, please ensure that the proper name, address and email address of the corresponding author are conspicuously indicated on the manuscript title page if he/she is not the outset writer of the paper.

Supplements

Y'all can contact our Editorial Staff at submission@europeanreview.org. Our team will exist able to provide advice and quotations for supplements.

Article Processing Charge (APC)

Standard Track*

• Manufactures up to eleven,000 characters, references, and spaces included, containing 1 figure and 1 half-page table, are published without accuse*.
• Articles up to 30,000 characters, references, and spaces included, containing two one-half-page figures and ii half-page tables, are published at the regular standard cost of Euro 950.00.
• Articles with more than than 30,000 characters, references, and spaces included, containing iv half-folio figures and iv half-folio tables, are published at Euro 1100.00.

Each additional half-folio tabular array costs Euro 100.00. Each additional half-page figure costs Euro 50.00.

Each supplementary tabular array costs Euro 100.00. Each supplementary figure costs Euro 50.00.

Notation: For articles paid from Italian republic, the fee of publication is plus VAT.

*This APC won't be applicable to manufactures submitted from May 1, 2022.

Superfast Runway

Nosotros offering a faster publication service for manuscripts. In one case a manuscript is accepted in its final form, it volition be published inside twoscore days from the payment date; total details are beneath.

The cost is Euro 1800.00 (plus VAT for payments from Italy) for manufactures including 4 half-page figures and four half-page tables.

Note: in that location is an additional fee – Euro 200.00 – for articles with over 45,000 characters (spaces included).

Each boosted one-half-page tabular array costs Euro 100.00. Each additional one-half-page figure costs Euro 50.00.

Each supplementary table costs Euro 100.00. Each supplementary figure costs Euro 50.00.

This process won't exist bachelor from July to Baronial.

Publication Fee Waivers *

Works made by Researchers from developing countries may exist bailiwick to special weather condition/benefits.

Authors coming from the countries included in the "Un list of Least Developed Countries" are entitled to enquire for a discount.

*Please be informed that applications for waivers have to be made during initial submission and non later an article has been accustomed. European Review for Medical and Pharmacological Sciences does not refund APCs once paid.

Corrections, erratum, and retractions

Corrections

After acceptance, authors cannot apply major corrections to the manuscript, Figures, Tables, or authorship. Earlier publication, nosotros ship galley proofs twice to authors. The authors are asked to carefully check them and send their approving for publication. After publication, no further corrections tin be applied. We publish corrections just when necessary, and, to ensure that corrections are handled consistently, one editor deals with them all.

We set no fourth dimension limit for notifying errors or publishing corrections. Anyway, we will evaluate corrections instance past instance.

In case authors discover a mistake between online and galley proof nosotros will ordinarily correct it by making the article right in the online version.

Erratum

We publish errata when a significant error has been detected in a published commodity and some changes are required. Pregnant mistakes involve tables, incorrect information, and spelling errors in case they modify the pregnant of the article. Corresponding authors should send an electronic mail stating the type of fault and the requested corrections. All authors accept to agree with an erratum. To ensure that corrections are handled consistently, one editor deals with them all.

To consequence errata, we follow the Council of Science Editors guidelines.

• An erratum observe linked to the commodity to be corrected volition be published in the outset available issue;
• The erratum notice will clearly country the championship and authors, the outcome of publication, the DOI, and the PMID in the erratum heading;
• Corrections will exist clearly stated in the erratum discover from the original version and the engagement(s) on which the changes were fabricated.;
• The erratum notice volition exist freely available to all readers online.
• Nosotros will mail a new article version with details of the changes.

Retractions

Retractions will exist considered past Eur Rev Med Pharmacol Sci in instance of evidence of unreliable data, plagiarism, unethical research, and misconduct. Nosotros consider an expression of business observe if an article is under investigation.

In item, the Editor in Main should consider retracting a publication following guidelines on Good Publication Practice every bit reported in COPE.

All requests of withdrawal must be sent past the respective writer who should provide detailed reasons for retraction. Authors should also provide a signed document stating that all authors agree with retraction and related reasons.

In case a 3rd party informs us near a mistake, issues or manipulation related to information or research itself, our Editor in Primary can decide to conduct an contained peer-review to establish whether our published information are reliable or accurate. The Editor in Chief can decide to withdraw an commodity without the consent of the authors in example of malpractice or axiomatic mistakes.

Retractions are issued following Good Publication Do guidelines as reported in COPE:

• A retraction find linked to the retracted article will be published in the in the first available upshot;
• The retraction notice will conspicuously state the title and authors, the issue of publication, the DOI, and the PMID in the retraction heading;
• The retraction find will be freely available to all readers and will state who is retracting the article and the detailed reason(southward) for retraction.

Plagiarism or Other Types of Unethical Publication Practice

Regarding plagiarism or other types of unethical publication do, Authors who want to publish in our Journal must follow the guidelines on Good Publication Practise as reported inCOPE and Council of Scientific discipline Editors. Moreover, for medical research involving man subjects, European Review for Medical and Pharmacological Sciences adheres to the guidelines of the Announcement of Helsinki. These guidelines aim to ensure that articles are published in a responsible and upstanding manner.

On a practical level, the starting time thing we do is conduct an early investigation using our anti‐plagiarism software(iThenticate® and Grammarly®). Our Periodical makes a plagiarism checker by a certificate plan on all the articles. Also, articles that are related to the suspected case of plagiarism or other unethical exercise are checked accuracy by either the reviewer feedback and observations or the Editors own observations. Our anti‐plagiarism software, however, volition not identify "salami slicing". So information technology is imperative that each example is looked at individually and, therefore, we exercise not abet the use of 1 statement of deportment to penalize the offender. Each case is considered separately and, equally editors, we volition need to decide if it is a deliberate activeness on the part of the author or information technology is due to a lack of understanding of the requirements of ethical writing. This tin can happen for new authors or some authors where translation to English is oft difficult. An instance of this is where there are no words/phrases in that language that interpret into English, and a developing practise that we noted is the 'borrowing' of words, phrases or often sentences that are considered advisable for what authors mean to say.

European Review for Medical and Pharmacological Sciences disapproves any kind of malpractice and unethical practice.

Third-party permission

Authors who wish to use copyrighted third-party content (divers as whatever material within the manuscript which is not the author's original work) must obtain permission from the copyright holder (commonly the original publisher). Tertiary-political party content may consist of figures, photos, illustrations, and may be establish in several places such as, but not limited to, websites, print, and online books and articles, theses, annual reports, briefing fabric, etc. Once obtained, documents certifying the permission to apply third-party content should be sent to submission@europeanreview.org for archiving purposes.

Preservation and Archiving

European Review for Medical and Pharmacological Sciences is committed to ensuring the permanent availability, accessibility and preservation of scholarly enquiry by upgrading digital file formats to comply with new applied science standards. All our files and manuscripts are archived and preserved in CLOCKSS.

washingtonhadvactice.blogspot.com

Source: https://www.europeanreview.org/how-to-submit-an-article

Share this post